Tuesday, May 11, 2021 1 PM EST Sign-Up HERE Pharmaceutical, medical device and life science companies continue to face escalating anti-corruption risks in the global marketplace.  Companies in these industries face a complex global maze of foreign government laws and regulations that create significant risks for global companies in these sectors. The U.S. Department of Justice, the Securities and Exchange Commission, and foreign law enforcement...